II
EXAS

IFM Investors’s Exact Sciences EXAS Stock Holding History

IFM Investors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,406
Closed -$1.36M – 635
2025
Q1 		$1.36M Sell
31,406
-1,613
-5% -$81.7K 0.01% 546
2024
Q4 		$1.86M Sell
33,019
-3,551
-10% -$221K 0.02% 523
2024
Q3 		$2.49M Sell
36,570
-1,438
-4% -$81.2K 0.02% 496
2024
Q2 		$1.61M Hold
38,008
– – 0.02% 556
2024
Q1 		$2.62M Buy
38,008
+126
+0.3% +$7.97K 0.03% 475
2023
Q4 		$2.8M Hold
37,882
– – 0.03% 438
2023
Q3 		$2.58M Buy
37,882
+339
+0.9% +$28.8K 0.03% 452
2023
Q2 		$3.53M Buy
37,543
+6,208
+20% +$484K 0.05% 383
2023
Q1 		$2.12M Buy
31,335
+3,093
+11% +$199K 0.03% 469
2022
Q4 		$1.4M Buy
28,242
+2,522
+10% +$103K 0.02% 541
2022
Q3 		$836K Hold
25,720
– – 0.02% 586
2022
Q2 		$1.01M Hold
25,720
– – 0.02% 574
2022
Q1 		$1.8M Buy
25,720
+3,709
+17% +$271K 0.03% 505
2021
Q4 		$1.71M Buy
22,011
+361
+2% +$31.9K 0.03% 503
2021
Q3 		$2.07M Buy
21,650
+135
+0.6% +$14.3K 0.04% 419
2021
Q2 		$2.67M Buy
21,515
+3,563
+20% +$425K 0.05% 356
2021
Q1 		$2.37M Buy
17,952
+2,929
+19% +$401K 0.06% 309
2020
Q4 		$1.99M Buy
15,023
+3,075
+26% +$372K 0.06% 303
2020
Q3 		$1.22M Buy
11,948
+1,116
+10% +$96.4K 0.05% 344
2020
Q2 		$942K Sell
10,832
-3,336
-24% -$267K 0.05% 370
2020
Q1 		$828K Sell
14,168
-355
-2% -$28.8K 0.04% 427
2019
Q4 		$1.34M Sell
14,523
-69
-0.5% -$6.07K 0.05% 389
2019
Q3 		$1.32M Buy
14,592
+6,449
+79% +$735K 0.05% 389
2019
Q2 		$961K Buy
+8,143
New +$820K 0.05% 362

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

IFM Investors's EXAS Position: Q2 2025 in Review

IFM Investors sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 31,406 shares — an estimated $1.36M sold.

IFM Investors first reported a position in EXAS in Q2 2019 and held it in 24 quarters. The position peaked at $3.53M in Q2 2023. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • IFM Investors reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • IFM Investors sold 31,406 Exact Sciences shares in Q2 2025, an estimated $1.36M.
  • IFM Investors first reported a position in Exact Sciences in Q2 2019 and held it in 24 quarters.
  • IFM Investors's Exact Sciences position peaked at $3.53M in Q2 2023.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on IFM Investors's 13F filing for Q2 2025, filed 11 Jul 2025.